CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- SC 13D/A Stake Beneficial Ownership Report
- 4 Insider Changes in Ownership
- 424B4 Offering Prospectus
- POS EX Other Post-effective Amendment
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 424B3 Offering Prospectus
- 8-K Event Shareholder vote results
- DRS Other Draft Registration Statement
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
Page 25 of 33 · 653 filings